Daiichi Sankyo is committed to bringing pharmaceutical innovation from bench to bedside. Innovation is paramount in all that we do, from pursuing new medicines and new methods of drug discovery and delivery, to achieving excellence throughout our organization.
Disclosure of Payments to Healthcare Professionals
A fruitful working relationship between the pharmaceutical industry and healthcare professionals has helped develop many life-saving medicines and has long been a positive driver for advancements in patient care and the progression of research.
EFPIA Disclosure Initiative
We fully support transparency and are prepared to disclose proper documentation of all our transfers of value, both to healthcare professionals (HCP) and healthcare organisations (HCO), under the EFPIA Disclosure Code and according country specific applicable laws and regulations.
Disclosure of Payments Report
- DS Europe Report 2020
- DS Europe Report 2019
- DS Europe Report 2018
- DS Europe Report 2017
- DS Europe Report 2016
- DS Europe Report 2015